StockWatch
·

Summit Therapeutics Inc.

Ticker: 1599298

values in millions

Revenue & Profit Trend

in millions
RevenueExpenditureNet Profit
-31.65-10.7610.1331.02Q2 FY21Q3 FY21Q1 FY22Q1 FY22Q2 FY22Q2 FY22Q3 FY22Q3 FY22

Margin Trend

percentage
OPM %NPM %
-102.00-100.67-99.33-98.00Q2 FY21Q3 FY21Q1 FY22Q1 FY22Q2 FY22Q2 FY22Q3 FY22Q3 FY22
PeriodQ3 FY22Q3 FY22Q2 FY22Q2 FY22Q1 FY22Q1 FY22Q3 FY21Q2 FY21
INCOME
Revenue0.22+0.0%0.22-8.3%0.24+0.0%0.24-4.0%0.25+0.0%0.25-80.9%1.31+2083.3%0.06
Total Income0.22+0.0%0.22-8.3%0.24+0.0%0.24-4.0%0.25+0.0%0.25-80.9%1.31+2083.3%0.06
EXPENSES
Expenditure17.16+0.0%17.16+32.7%12.93+0.0%12.93-42.3%22.41+0.0%22.41+7.7%20.80-12.6%23.79
Tax——————0.000.00
PROFIT
PBT——————-19.60+19.7%-24.42
Net Profit-21.39+0.0%-21.39-27.5%-16.77+0.0%-16.77+21.6%-21.40+0.0%-21.40-9.2%-19.60+19.7%-24.42
KEY METRICS
OPM %-100.00%-100.00%-100.00%-100.00%-100.00%-100.00%-100.00%-100.00%
NPM %-100.00%-100.00%-100.00%-100.00%-100.00%-100.00%-100.00%-100.00%
EPS-0.10+28.6%-0.14-16.7%-0.12+29.4%-0.17+22.7%-0.22-46.7%-0.15+25.0%-0.20+25.9%-0.27